Project Name：Colesevelam
Registration Classification：3.1
Formulations and specifications ：Tablets: 625mg; Suspension: 1.875g, 3.75g
Indications：Lowering cholesterol, lowering blood sugar
Original Research Company：U.S. Genzyme
Progress ：Pharmaceutical Research in progress
Category ：Antidiabetic drugs
